SAMD7
gene geneOn this page
Also known as DKFZp686E1583
Summary
SAMD7 (sterile alpha motif domain containing 7, HGNC:25394) is a protein-coding gene on chromosome 3q26.2, encoding Sterile alpha motif domain-containing protein 7 (Q7Z3H4). Component of a Polycomb group (PcG) multiprotein PRC1-like complex, essential for establishing rod photoreceptor cell identity and function by silencing nonrod gene expression in developing rod photoreceptor cells.
Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific; chromatin binding activity; and histone binding activity. Predicted to be involved in negative regulation of DNA-templated transcription; negative regulation of gene expression, epigenetic; and retinal rod cell development. Predicted to be located in cytoplasm. Predicted to be part of PRC1 complex. Predicted to be active in nucleus. Implicated in macular degeneration.
Source: NCBI Gene 344658 — RefSeq curated summary.
At a glance
- Gene–disease (curated): macular dystrophy with or without cone dysfunction (Strong, GenCC)
- Clinical variants (ClinVar): 68 total — 5 pathogenic
- Phenotypes (HPO): 11
- MANE Select transcript:
NM_001304366
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25394 |
| Approved symbol | SAMD7 |
| Name | sterile alpha motif domain containing 7 |
| Location | 3q26.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp686E1583 |
| Ensembl gene | ENSG00000187033 |
| Ensembl biotype | protein_coding |
| OMIM | 620493 |
| Entrez | 344658 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay
ENST00000335556, ENST00000428432, ENST00000487910
RefSeq mRNA: 2 — MANE Select: NM_001304366
NM_001304366, NM_182610
CCDS: CCDS3209
Canonical transcript exons
ENST00000335556 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001333464 | 169925058 | 169925136 |
| ENSE00001333466 | 169921214 | 169921338 |
| ENSE00001333470 | 169938318 | 169939175 |
| ENSE00001333471 | 169919458 | 169919584 |
| ENSE00001345467 | 169915367 | 169915441 |
| ENSE00001345474 | 169911572 | 169911821 |
| ENSE00003560424 | 169928457 | 169928578 |
| ENSE00003571431 | 169926553 | 169927181 |
| ENSE00003628905 | 169936339 | 169936449 |
Expression profiles
Bgee: expression breadth tissue_specific, 3 present calls, max score 40.36.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0430 / max 38.0700, expressed in 4 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 39679 | 0.0259 | 4 |
| 39680 | 0.0171 | 3 |
Top tissues by expression
125 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 40.36 | gold quality |
| lymph node | UBERON:0000029 | 40.24 | gold quality |
| cortical plate | UBERON:0005343 | 40.04 | gold quality |
| bone marrow cell | CL:0002092 | 38.26 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.26 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| bone marrow | UBERON:0002371 | 36.53 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| tonsil | UBERON:0002372 | 35.63 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| monocyte | CL:0000576 | 30.88 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.81 | gold quality |
| leukocyte | CL:0000738 | 30.58 | gold quality |
| blood | UBERON:0000178 | 30.22 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.51 | gold quality |
| right uterine tube | UBERON:0001302 | 28.76 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| urinary bladder | UBERON:0001255 | 27.89 | gold quality |
| frontal cortex | UBERON:0001870 | 27.52 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.50 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 26.98 | gold quality |
| adrenal tissue | UBERON:0018303 | 26.96 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.88 | gold quality |
| cortex of kidney | UBERON:0001225 | 26.87 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 30.21 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CRX
miRNA regulators (miRDB)
28 targeting SAMD7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-130B-5P | 99.83 | 68.50 | 1888 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
| HSA-MIR-6716-5P | 99.56 | 68.62 | 1244 |
| HSA-MIR-136-5P | 99.50 | 67.26 | 1153 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-6128 | 99.33 | 67.83 | 1581 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-3926 | 98.95 | 69.26 | 1438 |
| HSA-MIR-3127-3P | 98.94 | 67.34 | 1055 |
| HSA-MIR-6756-3P | 98.94 | 66.79 | 1104 |
| HSA-MIR-5197-3P | 98.71 | 67.05 | 1905 |
| HSA-MIR-548S | 98.50 | 67.17 | 1213 |
| HSA-MIR-892B | 98.00 | 67.11 | 821 |
| HSA-MIR-4712-5P | 97.24 | 67.79 | 775 |
| HSA-MIR-770-5P | 97.24 | 68.10 | 758 |
| HSA-MIR-6772-3P | 97.04 | 65.89 | 784 |
| HSA-MIR-6823-5P | 96.26 | 65.69 | 919 |
Literature-anchored findings (GeneRIF, showing 3)
- Data have identified a novel retinal SAM domain protein, Samd7, which could act as a transcriptional repressor involved in fine-tuning of Crx-regulated gene expression. (PMID:23565263)
- Autosomal recessive retinitis pigmentosa with homozygous rhodopsin mutation E150K and non-coding cis-regulatory variants in CRX-binding regions of SAMD7. (PMID:26887858)
- Mutations in SAMD7 cause autosomal-recessive macular dystrophy with or without cone dysfunction. (PMID:38272031)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | samd7 | ENSDARG00000060354 |
| mus_musculus | Samd7 | ENSMUSG00000051860 |
| rattus_norvegicus | Samd7 | ENSRNOG00000027995 |
| drosophila_melanogaster | l(3)mbt | FBGN0002441 |
| drosophila_melanogaster | Sfmbt | FBGN0032475 |
| caenorhabditis_elegans | lin-61 | WBGENE00003041 |
| caenorhabditis_elegans | mbtr-1 | WBGENE00021661 |
Paralogs (18): SCMH1 (ENSG00000010803), MBTD1 (ENSG00000011258), SCML1 (ENSG00000047634), L3MBTL2 (ENSG00000100395), SCML2 (ENSG00000102098), PHC1 (ENSG00000111752), THAP10 (ENSG00000129028), PHC2 (ENSG00000134686), SAMD1 (ENSG00000141858), SCML4 (ENSG00000146285), L3MBTL4 (ENSG00000154655), SFMBT1 (ENSG00000163935), PHC3 (ENSG00000173889), L3MBTL1 (ENSG00000185513), SAMD11 (ENSG00000187634), SFMBT2 (ENSG00000198879), L3MBTL3 (ENSG00000198945), SAMD13 (ENSG00000203943)
Protein
Protein identifiers
Sterile alpha motif domain-containing protein 7 — Q7Z3H4 (reviewed: Q7Z3H4)
All UniProt accessions (2): F8WDF1, Q7Z3H4
UniProt curated annotations — full annotation on UniProt →
Function. Component of a Polycomb group (PcG) multiprotein PRC1-like complex, essential for establishing rod photoreceptor cell identity and function by silencing nonrod gene expression in developing rod photoreceptor cells. Via its association with the PRC1-like complex, promotes epigenetic repressive marks H3K27me3 and H2AK119ub marks in nonrod genes, silencing their transcription. Represses Crx-controlled photoreceptor-specific gene expression.
Subunit / interactions. Monomer, homodimer and homooligomer. Component of a Polycomb group (PcG) multiprotein PRC1-like complex. Interacts with PHC2, NR2E3 and SAMD11. Interacts with RNF1 in a PHC2-dependent manner.
Subcellular location. Nucleus. Cytoplasm.
Tissue specificity. Expressed in the retina (at protein level). Expressed in the retinal inner and outer nuclear layers.
Disease relevance. Macular dystrophy with or without cone dysfunction (MDCD) [MIM:620762] A form of macular dystrophy, a retinal disease in which various forms of deposits, pigmentary changes, and atrophic lesions are observed in the macula lutea. MDCD is a progressive, autosomal recessive form characterized by reduced visual acuity and macular atrophy involving the fovea. Some patients also exhibit mild generalized cone dysfunction. The disease is caused by variants affecting the gene represented in this entry.
Domain organisation. The SAM domain mediates its oligomerization and localization to nuclear polycomb bodies.
RefSeq proteins (2): NP_001291295, NP_872416 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001660 | SAM | Domain |
| IPR013761 | SAM/pointed_sf | Homologous_superfamily |
| IPR050548 | PcG_chromatin_remod_factors | Family |
Pfam: PF00536
UniProt features (9 total): region of interest 3, sequence variant 3, chain 1, domain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z3H4-F1 | 56.48 | 0.22 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 91 (showing top):
AREB6_01, GOBP_NEUROGENESIS, GOBP_NEURAL_RETINA_DEVELOPMENT, chr3q26, GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION, TGCTGAY_UNKNOWN, WTGAAAT_UNKNOWN, GOBP_PHOTORECEPTOR_CELL_DEVELOPMENT, GOBP_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION, GOBP_PHOTORECEPTOR_CELL_DIFFERENTIATION, GOCC_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX, GOBP_SENSORY_ORGAN_DEVELOPMENT, GOBP_SENSORY_ORGAN_MORPHOGENESIS
GO Biological Process (5): negative regulation of gene expression, epigenetic (GO:0045814), negative regulation of DNA-templated transcription (GO:0045892), retinal rod cell development (GO:0046548), negative regulation of transcription by RNA polymerase II (GO:0000122), negative regulation of gene expression (GO:0010629)
GO Molecular Function (4): DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), chromatin binding (GO:0003682), histone binding (GO:0042393), protein binding (GO:0005515)
GO Cellular Component (3): nucleus (GO:0005634), cytoplasm (GO:0005737), PRC1 complex (GO:0035102)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 2 |
| negative regulation of gene expression | 1 |
| epigenetic regulation of gene expression | 1 |
| DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| eye photoreceptor cell development | 1 |
| retinal rod cell differentiation | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| gene expression | 1 |
| regulation of gene expression | 1 |
| negative regulation of macromolecule biosynthetic process | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| protein binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| nuclear ubiquitin ligase complex | 1 |
| PcG protein complex | 1 |
Protein interactions and networks
STRING
352 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SAMD7 | NR2E3 | Q9Y5X4 | 649 |
| SAMD7 | SMAD7 | O15105 | 596 |
| SAMD7 | GPR160 | Q9UJ42 | 530 |
| SAMD7 | SAMD14 | Q8IZD0 | 527 |
| SAMD7 | LRIT1 | Q9P2V4 | 489 |
| SAMD7 | OPN1SW | P03999 | 474 |
| SAMD7 | OTOS | Q8NHW6 | 471 |
| SAMD7 | SAMD10 | Q9BYL1 | 410 |
| SAMD7 | COPS9 | Q8WXC6 | 396 |
| SAMD7 | CRX | O43186 | 392 |
| SAMD7 | SAMD5 | Q5TGI4 | 387 |
| SAMD7 | SEC62 | Q99442 | 386 |
| SAMD7 | PCBP4 | P57723 | 364 |
| SAMD7 | SAMD1 | Q6SPF0 | 361 |
| SAMD7 | ATP1A1 | P05023 | 353 |
IntAct
32 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KRTAP6-3 | SAMD7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAMD7 | KRTAP3-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-2 | SAMD7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OIP5 | SAMD7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM168B | SAMD7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAMD7 | TSC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAMD7 | WFS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAMD7 | KIF1B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAMD7 | RNF11 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAMD7 | GAPDHS | psi-mi:“MI:0914”(association) | 0.530 |
| SAMD7 | KRTAP6-3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SAMD7 | KRTAP3-1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SAMD7 | FAM168B | psi-mi:“MI:0915”(physical association) | 0.000 |
| SAMD7 | KRTAP6-2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SAMD7 | OIP5 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SAMD7 | TSC1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (19): GAPDHS (Affinity Capture-MS), SON (Affinity Capture-MS), KLHL15 (Affinity Capture-MS), SAMD11 (Affinity Capture-MS), SAMD7 (Synthetic Growth Defect), SAMD11 (Affinity Capture-MS), GAPDHS (Affinity Capture-MS), FBP1 (Affinity Capture-MS), KLHL15 (Affinity Capture-MS), SAMD7 (Synthetic Lethality), SAMD7 (Two-hybrid), SAMD7 (Two-hybrid), SAMD7 (Two-hybrid), SAMD7 (Two-hybrid), KRTAP3-1 (Two-hybrid)
ESM2 similar proteins: A0A1W2PPF3, A1YFX5, A5WWA0, A6NFE2, B0S6S9, D2HQI1, D3Z987, F1M5M3, F1MJR8, G3X9P6, O15016, O35892, P70347, Q14DL0, Q1X8D7, Q32L17, Q3UPF5, Q3V0M2, Q4KL20, Q52KR3, Q5DTZ0, Q5IR70, Q5XIP4, Q5Z8V7, Q66H65, Q68FV5, Q6TXF5, Q7M6U3, Q7XWS7, Q7Z3H4, Q86UW6, Q86XD8, Q8C5U9, Q8CCC3, Q8CEE6, Q8IV76, Q8IWB6, Q8IYU4, Q8IYW4, Q8K0B3
Diamond homologs: A2A5N8, B1B1A0, D3YUG0, D3YXK1, D3ZWK4, E1C2V1, O02274, O60284, O95251, P39769, P59178, P70047, P70475, P78364, P97500, Q01538, Q05BQ5, Q1JQD9, Q1RNF8, Q29L50, Q32N90, Q3MIF2, Q4V7W5, Q5DTW2, Q5R737, Q5SVQ0, Q5VUG0, Q5VXD3, Q64028, Q6DIN3, Q6P5G3, Q6SPE9, Q6SPF0, Q7Z3H4, Q80TY4, Q810T5, Q8BLB7, Q8C8Y5, Q8CFC2, Q8CHP6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 5 |
| Likely pathogenic | 0 |
| Uncertain significance | 58 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (5)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3062149 | NM_001304366.2(SAMD7):c.290+1G>A | Pathogenic |
| 3062150 | NM_001304366.2(SAMD7):c.919+1G>A | Pathogenic |
| 3062151 | NM_001304366.2(SAMD7):c.211+1G>A | Pathogenic |
| 3062152 | NM_001304366.2(SAMD7):c.1153G>A (p.Val385Ile) | Pathogenic |
| 3062153 | NM_001304366.2(SAMD7):c.992A>T (p.Asp331Val) | Pathogenic |
SpliceAI
1187 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:169911818:GGAT:G | donor_gain | 1.0000 |
| 3:169911819:G:GT | donor_gain | 1.0000 |
| 3:169911819:GAT:G | donor_gain | 1.0000 |
| 3:169911822:G:GG | donor_gain | 1.0000 |
| 3:169911826:G:GG | donor_gain | 1.0000 |
| 3:169927180:AGG:A | donor_loss | 1.0000 |
| 3:169927183:T:G | donor_loss | 1.0000 |
| 3:169928453:AAAG:A | acceptor_gain | 1.0000 |
| 3:169911817:AGGAT:A | donor_gain | 0.9900 |
| 3:169911818:GGATG:G | donor_gain | 0.9900 |
| 3:169911820:AT:A | donor_gain | 0.9900 |
| 3:169911822:G:A | donor_loss | 0.9900 |
| 3:169911823:T:A | donor_loss | 0.9900 |
| 3:169921213:GAGAT:G | acceptor_gain | 0.9900 |
| 3:169925133:CCAGG:C | donor_loss | 0.9900 |
| 3:169925134:CAGG:C | donor_loss | 0.9900 |
| 3:169925135:AGGTA:A | donor_loss | 0.9900 |
| 3:169925136:GG:G | donor_loss | 0.9900 |
| 3:169925138:T:A | donor_loss | 0.9900 |
| 3:169928448:A:AG | acceptor_gain | 0.9900 |
| 3:169928449:T:G | acceptor_gain | 0.9900 |
| 3:169928451:TTAAA:T | acceptor_loss | 0.9900 |
| 3:169928452:TAAA:T | acceptor_loss | 0.9900 |
| 3:169928453:A:AG | acceptor_gain | 0.9900 |
| 3:169928454:A:G | acceptor_gain | 0.9900 |
| 3:169928454:AAGG:A | acceptor_loss | 0.9900 |
| 3:169928455:A:AT | acceptor_loss | 0.9900 |
| 3:169928455:A:G | acceptor_gain | 0.9900 |
| 3:169928589:GTT:G | donor_gain | 0.9900 |
| 3:169928590:TTT:T | donor_gain | 0.9900 |
AlphaMissense
2936 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:169936343:T:C | F349S | 0.998 |
| 3:169928516:T:A | W327R | 0.997 |
| 3:169928516:T:C | W327R | 0.997 |
| 3:169936358:T:A | I354N | 0.997 |
| 3:169936373:T:C | L359S | 0.997 |
| 3:169936415:T:C | L373S | 0.997 |
| 3:169936342:T:C | F349L | 0.996 |
| 3:169936344:T:A | F349L | 0.996 |
| 3:169936344:T:G | F349L | 0.996 |
| 3:169936397:T:C | L367P | 0.996 |
| 3:169936364:G:T | G356V | 0.995 |
| 3:169936382:T:A | L362H | 0.995 |
| 3:169936364:G:A | G356E | 0.994 |
| 3:169936382:T:C | L362P | 0.994 |
| 3:169936433:T:C | L379P | 0.994 |
| 3:169936439:T:C | I381T | 0.994 |
| 3:169928518:G:C | W327C | 0.992 |
| 3:169928518:G:T | W327C | 0.992 |
| 3:169928540:T:C | F335L | 0.992 |
| 3:169928542:C:A | F335L | 0.992 |
| 3:169928542:C:G | F335L | 0.992 |
| 3:169928541:T:C | F335S | 0.991 |
| 3:169936358:T:G | I354S | 0.991 |
| 3:169936397:T:A | L367H | 0.991 |
| 3:169936439:T:G | I381S | 0.991 |
| 3:169936343:T:G | F349C | 0.990 |
| 3:169936437:A:C | K380N | 0.989 |
| 3:169936437:A:T | K380N | 0.989 |
| 3:169928561:T:C | C342R | 0.987 |
| 3:169936423:G:A | G376R | 0.986 |
dbSNP variants (sampled 300 via entrez): RS1000096728 (3:169915429 G>A), RS1000147407 (3:169915697 G>C), RS1000210595 (3:169920392 T>A), RS1000242824 (3:169929599 T>C), RS1000526160 (3:169928207 A>C), RS1000578494 (3:169927955 A>G), RS1001043124 (3:169910775 A>T), RS1001154741 (3:169927475 T>C), RS1001196414 (3:169931617 G>A,C), RS1001211429 (3:169921741 A>T), RS1001247203 (3:169931355 T>C), RS1001458351 (3:169934024 G>A), RS1001478806 (3:169909573 G>C,T), RS1001662627 (3:169921998 A>G,T), RS1001740430 (3:169937700 A>C,G)
Disease associations
OMIM: gene MIM:620493 | disease phenotypes: MIM:620762
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| macular dystrophy with or without cone dysfunction | Strong | Autosomal recessive |
Mondo (1): macular dystrophy with or without cone dysfunction (MONDO:0958326)
Orphanet (0):
HPO phenotypes
11 total (11 of 11 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000603 | Central scotoma |
| HP:0003596 | Middle age onset |
| HP:0003621 | Juvenile onset |
| HP:0007401 | Macular atrophy |
| HP:0007663 | Reduced visual acuity |
| HP:0007722 | Retinal pigment epithelial atrophy |
| HP:0007754 | Macular dystrophy |
| HP:0011462 | Young adult onset |
| HP:0012511 | Temporal optic disc pallor |
| HP:0025159 | Hypoautofluorescent retinal lesion |
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Air Pollutants | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Permethrin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: macular dystrophy with or without cone dysfunction
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): macular dystrophy with or without cone dysfunction